368 filings
8-K
ATXI
Avenue Therapeutics Inc
23 May 24
Other Events
8:30am
10-Q
2024 Q1
ATXI
Avenue Therapeutics Inc
Quarterly report
15 May 24
4:15pm
8-K
ATXI
Avenue Therapeutics Inc
15 May 24
Avenue Therapeutics Reports First Quarter 2024 Financial Results and Recent Corporate Highlights
9:01am
EFFECT
ATXI
Avenue Therapeutics Inc
13 May 24
Notice of effectiveness
12:15am
424B3
ATXI
Avenue Therapeutics Inc
10 May 24
Prospectus supplement
4:53pm
424B5
a5a0e3bidak
10 May 24
Prospectus supplement for primary offering
4:52pm
DEFA14A
zho73 6638
3 May 24
Additional proxy soliciting materials
6:03pm
SC 13G/A
p0mk5xa akuo62ohm
2 May 24
AVENUE THERAPEUTICS / Davidow Robert L ownership change
4:02pm
8-K
okad16d56w
1 May 24
Avenue Therapeutics Announces Exercise of Warrants for $4.4 Million in Gross Proceeds
4:28pm
8-K
bb87ho ggmal3x4ml0
26 Apr 24
Avenue Therapeutics Announces Reverse Stock Split
4:39pm
SC 13D/A
ivnzydohntjiexap5
17 Apr 24
AVENUE THERAPEUTICS / Fortress Biotech ownership change
4:05pm
4
kjs2plkrgwhdn pw
17 Apr 24
Change in insider ownership
4:05pm
8-K
drpss03ave izapb5v
29 Mar 24
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
2:41pm
DEF 14C
uk8ij3 x26
18 Mar 24
Information statement
4:59pm
8-K
ys0n8cu7n
18 Mar 24
Avenue Therapeutics Reports Full Year 2023 Financial Results and Recent Corporate Highlights
4:10pm
8-K
li66vu9tvw7trwp0hgxq
15 Mar 24
Other Events
7:15am
PRE 14C
g0gpx95x2zu4lgz p1t
8 Mar 24
Preliminary information
4:31pm
8-K
nayetqsj9f5 8wrloipl
8 Mar 24
Submission of Matters to a Vote of Security Holders
4:15pm
8-K
wxr255lnxurbt1
23 Feb 24
Amendments to Articles of Incorporation or Bylaws
4:17pm